Autres langues ZIVO Bioscience, Inc.

Actions

ZIVO

US98978N3098

Temps Différé OTC Markets Autres places de cotation 20:43:36 30/04/2024			Varia. 5j.	Varia. 1 janv.
7,9 ^USD	+20,61%		-2,47%	+558,33%

15/03	ZIVO Bioscience, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI
07/02	ZIVO Bioscience, Inc. annonce des résultats supplémentaires d'une étude positive de 42 jours sur la coccidiose	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

ZIVO Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	15/03
ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study	07/02
ZIVO Bioscience, Inc. Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study	07/02
ZIVO Bioscience Announces Uplisting to OTCQB Market	29/01
Zivo Bioscience Reports Positive Efficacy Results from 42-Day Validation Study with Non-Antibiotic Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens	23/01
ZIVO Bioscience, Inc. announced that it has received $0.531142 million in funding	16/01
ZIVO Bioscience, Inc. announced that it expects to receive $0.531142 million in funding	04/01
ZIVO Bioscience, Inc. announced that it has received $0.308936 million in funding	27/12
ZIVO Bioscience, Inc. announced that it expects to receive $0.308936 million in funding	12/12
ZIVO Bioscience, Inc. announced that it has received $0.2 million in funding	05/12
ZIVO Bioscience, Inc.(NasdaqCM:ZIVO) dropped from S&P TMI Index	29/11
ZIVO Bioscience, Inc.(OTCPK:ZIVO) dropped from NASDAQ Composite Index	24/11
ZIVO Bioscience, Inc. announced that it expects to receive $0.15 million in funding	16/11
ZIVO Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
Zivo Bioscience Insider Bought Shares Worth $199,600, According to a Recent SEC Filing	30/10/23
ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens	30/10/23
ZIVO Bioscience Announces Reverse Stock Split	26/10/23
ZIVO Bioscience : Dawon James Small Cap Growth Conference Presentation	12/10/23
ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference	03/10/23
Trial Results Confirm Efficacy of ZIVO Bioscience's Non-Antibiotic Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler Chickens	20/09/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues ZIVO Bioscience, Inc.

Actions

ZIVO

US98978N3098

Autres langues

Filtres